Global Heart Valve Devices Market Report and Forecast 2025-2034

Global Heart Valve Devices Market Outlook

The global heart valve devices market size was valued at USD 10.3 billion in 2023, driven by the increasing incidence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 12.9% during the forecast period of 2024-2032 to achieve a value of USD 30.7 billion by 2032.

Heart Valve Devices: Introduction

A heart valve is a one-way valve that allows blood to pass through the heart only in one direction. In a mammalian heart, the four valves are frequently represented to show the blood flow pattern through the heart. Depending on the blood pressure differences on each side, a heart valve may open or close as needed. The valves occasionally fail to open or seal precisely. This happens when the blood flow from the heart to the rest of the body is obstructed. It is also known as heart valve disease, and the course of treatment for this condition varies on the heart valve in question as well as the type and degree of the disease.

Global Heart Valve Devices Market Analysis

The global market for heart valve devices is experiencing a surge in growth driven by several key trends. The key trends in the market include increased investments by the key players in the market. For example, Xeltis' successful fundraising is propelling the development of advanced restorative cardiovascular devices. Xeltis, a pioneering medical technology company, is a leader in heart valve replacement and vascular therapies, with the aim of providing patients worldwide access to cutting-edge treatments.

Furthermore, increased research and development activities focused on finding optimal treatments for cardiovascular diseases are significantly proeplling the global heart valve replacement market growth as well. The newly launched products by the key players in the market are also enhancing the market value. For example, minimally invasive procedures like the EVOQUE tricuspid valve replacement system shorten patient recovery times and improve outcomes. This investigational device offers a less invasive alternative to open-heart surgery, showcasing the relentless pursuit of innovative solutions in cardiovascular care.

Additionally, the increased number of clinical trials conducted by key players is further fueling the market growth. For example, Abbott highlights the commitment to advancing treatment options. Abbott's successful clinical trial involving tricuspid valve clipping demonstrates the continuous efforts to enhance patient outcomes and reduce risks.

In conclusion, these market trends collectively contribute to the robust global heart valve devices market growth.

Global Heart Valve Devices Market Segmentations

Market Breakup by Product Type

• Mechanical Heart Valves

• Biological Heart Valves

• Transcatheter Valves

Market Breakup by Treatment

• Open Surgery

• Minimally Invasive Surgery (MIS)

Market Breakup by End User

• Hospitals

• Speciality Clinics

• Home Healthcare

• Others

Market Breakup by Region

• North America

• Europe 

• Asia Pacific

• Latin America

• Middle East and Africa

Global Heart Valve Devices Market Overview

The market is experiencing robust growth driven by the rising number of various heart diseases worldwide, with coronary heart disease being a significant contributor to cardiovascular-related mortality. This prevalence emphasizes the growing demand for advanced heart valve devices to address these conditions. Additionally, there is a substantial shift in preference toward minimally invasive treatment strategies, particularly for complex heart disorders like mitral regurgitation. This shift aligns with the increasing advancements in technology, leading to the development of exceptional products in the market. Continuous innovation in valve technologies by medical device manufacturers is creating new opportunities for the market, further propelling the global heart valve devices market growth.

Geographically, North America is currently leading the regional market and is expected to lead the market in the coming years as well. The region has the presence of a robust healthcare system and key market players. The market is further driven by increased awareness among people regarding the benefits of minimally invasive procedures and robot-assisted surgeries. These drivers collectively contribute to the thriving global heart valve devices market.

Global Heart Valve Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• AgaMatrix Holdings LLC

• Coloplast Corp

• 3M Co.

• Cardinal Health

• ConvaTec Inc.

• B. Braun Melsungen AG

• SMITH & NEPHEW

• Convatec Group PLC

• Medline Industries

• Integra Lifesciences Corp.

• Mckesson Corporation

• Dermarite Industries, LLC

• Amerx Health Care Corp

Key Highlights of the Report